America’s “tech cash shell” boom
America's tech companies are eschewing going public through an IPO and opting to use “special purpose acquisition companies” (SPACs) – also known as cash shells – instead.

Special purpose acquisition companies (SPACs) – also known as cash shells – have “suddenly become the hottest way to raise capital, especially in tech”, says Kara Swisher in The New York Times. A SPAC raises money through an initial public offering (IPO), then uses the cash to buy a business that wants to list on the stockmarket but doesn’t want to go through the IPO process. As such, they are “essentially a back door to taking a start-up public”.
This appeals to many tech entrepreneurs, who believe that the investment banks that carry out IPOs tend to underprice them, leaving “billions on the table that should go to the companies, and not to Wall Street firms and their clients”. What’s more, most detest the hassle of taking part in an IPO: ”often they compare it to dental implant surgery”. So as the tech sector booms, so do SPACs: there have been 75 new SPAC listings in the US this year, raising more than $30bn.
There is another way to go public without an IPO, notes Yun Li on CNBC: a direct listing, when a firm simply lists its shares on the exchange. The limitation is that it can’t raise new capital at the same time – only existing investors can sell their shares. But last month US regulators approved new rules that will let firms carrying out a direct listing on the New York Stock Exchange and sell new shares on the first day of trading. This “could curb some of the enthusiasm in the booming SPAC market, as it provides similar advantages”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
Four income funds to add to your ISA
Adding one of these four income funds to your stocks and shares ISA ahead of tax year end could pay dividends
By Dan McEvoy Published
-
Are regular savings accounts worth it?
A 7% interest rate is eye-catching, but how much can you save in a regular saver account and how does the interest rate work exactly?
By Ruth Emery Published
-
Three top-notch Taiwanese companies cashing in on the advent of AI
Opinion Eric Chan, investment director and co-manager of the Aberdeen Asian Income Fund, highlights three potential Taiwanese winners in the technology industry
By Eric Chan Published
-
Weight-loss drugs could revolutionise the economy – the investments to buy now
The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with food and revolutionise the economy
By Dr Matthew Partridge Published
-
Find tomorrow’s Asian giants while they are still smaller companies
Opinion Nitin Bajaj, portfolio manager of the Fidelity Asian Values trust, picks three Asian companies to invest in.
By Nitin Bajaj Published
-
AI will maintain Moody’s market lead, says Stephen Connolly
Opinion Veteran data provider Moody's has adapted well to the modern world, and is one of Warren Buffett’s longest-held investments
By Stephen Connolly Published
-
Is BlackRock World Mining gearing for a recovery?
Opinion After a frustrating year, BlackRock World Mining is positioned for growth and to capitalise on the sector's recovery
By Rupert Hargreaves Published
-
Should you limit exposure to US tech stocks?
An end to the AI boom would shake both US funds and global trackers. Here’s one way to trim exposure to US tech stocks
By Cris Sholto Heaton Published
-
The mystery of America’s gold and why an audit matters
How much gold does the US actually have? Dominic Frisby explains why it matters
By Dominic Frisby Published
-
Art vs AI: artists’ uprising takes on the bots
AI performs impressively, but it’s all based on human work that was taken without payment. The government thinks this is fine. Copyright holders beg to differ
By Simon Wilson Published